Table 3.
Variable | Weight Loss (n=26) | Control (n=14) | ||
---|---|---|---|---|
Baseline | 16 Weeks | Baseline | 16 Weeks | |
C-reactive protein (mg/L) | 2.3 ± 0.5 | 1.7 ± 0.4 | 2.0 ± 0.6 | 1.4 ± 0.3 |
Interleukin-6 (pg/ml) | 1.2 ± 0.2 | 1.1 ± 0.1 | 1.0 ± 0.17 | 1.4 ± 0.2 |
Tumor-necrosis factor-α (pg/ml) | 1.6 ± 0.2 | 1.4 ± 0.1 | 2.9 ± 1.1 | 2.5 ± 0.7 |
Oxidized LDL (U/L) | 69 ± 4 | 57 ± 4*† | 65 ± 5 | 67 ± 4 |
Total antioxidant status (mg/dl) | 1.34 ± 0.04 | 1.27 ± 0.04 | 1.33 ± 0.05 | 1.34 ± 0.06 |
Adiponectin (μg/ml) | 11.7 ± 1.7 | 11.4 ± 1.4 | 8.0 ± 1.6 | 8.0 ± 1.5 |
Leptin (ng/ml) | 17.6 ± 2.2 | 10.5 ± 1.9*† | 13.5 ± 1.5 | 14.5 ± 2.1 |
Norepinephrine (pg/ml) | 209 ± 15 | 211 ± 25 | 167 ± 19 | 174 ± 18 |
Aldosterone (ng/dl) | 5.6 ± 0.6 | 5.2 ± 0.8 | 7.0 ± 1.2 | 7.2 ± 1.3 |
Endothelin-1 (pg/ml) | 6.6 ± 0.3 | 6.6 ± 0.3 | 5.9 ± 0.4 | 6.6 ± 0.4 |
Cortisol (μg/ml) | 12.0 ± 1.0 | 9.8 ± 0.7 | 12.8 ± 1.3 | 10.0 ± 1.3 |
Free fatty acids (μmol/L) | 715 ± 56 | 655 ± 47 | 577 ± 62 | 604 ± 66 |
Values are mean ± standard error;
P<0.05 vs. Pre;
P<0.05 group (Weight loss, Control) × time (Pre, Post) interaction.